3i T3® DCD® BNPT6511Recalls & reported problems
ZimVie US Corp LLC · 3i T3® WITH DCD® TAPERED IMPLANT 6/5 X 11.5MM · Class 2 · Implant
All models of 3i T3 DCD (73)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 6
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00844868029519), received between Aug 14, 2020 and Sep 28, 2023 — classified as 6 injuries.
The most frequently reported specific device problem is “Patient-Device Incompatibility” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem5
- Patient-Device Incompatibility1
Patient problems
- Unspecified Infection5
- Inflammation2
- No Code Available2
- Osteolysis2
- Pain2
- Discomfort1
- Hypersensitivity/Allergic reaction1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
InjurySep 28, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PATIENT EXPERIENCED PERI-IMPLANTITIS AT IMPLANT TOOTH SITE #30, WITH ASSOCIATED PAIN AND INFLAMMATION. THE IMPLANT/CROWN ALL BECAME LOOSE AND EVENTUALLY THE IMPLANT LOST ITS INTEGRATION AND WAS REMOVED.
Patient problems: Osteolysis; Pain; Unspecified Infection
MAUDE report 17833804 ↗InjuryJul 31, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE IMPLANT AT TOOTH SITE #30 LOST INTEGRATION DUE TO PERI-IMPLANTITIS AT THE IMPLANT SITE AND WAS REMOVED. SYMPTOMS AS A RESULT OF THE EVENT: INFLAMMATION.
Patient problems: Osteolysis; Unspecified Infection
MAUDE report 17423869 ↗InjurySep 8, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE IMPLANTS AT TOOTH SITES 12, 13, AND 14 WERE REMOVED DUE TO INFECTION. NOTED PATIENT HAD POST NASAL DRIP AND CONGESTION. SITE WAS GRAFTED WITH ALLOGRAFT TOGETHER WITH IMPLANT PLACEMENT. SYMPTOMS AS A RESULT OF THE EVENT: POST NASAL DRIP, CONGESTION AND INFLAMMATION.
Patient problems: Inflammation; Unspecified Infection
MAUDE report 15380349 ↗InjuryDec 9, 2021Patient-Device Incompatibility; Patient-Device Incompatibility
IT WAS REPORTED BY CUSTOMER THAT THE IMPLANT WAS REMOVED DUE TO ALLERGIC REACTION. DISCOMFORT AFTER HEALING, PATIENT REQUESTED REMOVAL. PAIN WAS REPORTED. PATIENT WILL RETURN FOR AN ADDITIONAL APPOINTMENT. TOOTH# 15.
Patient problems: Discomfort; Hypersensitivity/Allergic reaction; Pain
MAUDE report 12972994 ↗InjurySep 1, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT IMPLANT AT TOOTH SITE # 12 WAS REMOVED DUE TO PERI-IMPLANTITIS. SITE GRAFTED. ADDITIONAL APPOINTMENTS IMPLANT RE-PLACEMENT: NOT INDICATED. SYMPTOMS AS A RESULT OF THE EVENT: PERI-IMPLANTITIS.
Patient problems: No Code Available; Unspecified Infection
MAUDE report 10480733 ↗InjuryAug 14, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT IMPLANT (BNPT6511) WAS REMOVED DUE TO PERI-IMPLANTITIS AT TOOTH LOCATION 14. SITE WAS BONE GRAFTED. INFLAMMATION, BONE LOSS WERE ALSO NOTED.
Patient problems: Inflammation; No Code Available; Unspecified Infection
MAUDE report 10408794 ↗
Other IMPLANT, ENDOSSEOUS, ROOT-FORM devices
- Straumann® Dental Implant System Roxolid® SLA Impl. SLA Roxolid BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM43,616 reports
- STRAUMANN BONE LEVEL TAPERED IMPLANT SLActive Roxolid BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM40,404 reports
- Straumann® Dental Implant System Roxolid® SLA Impl. SLA Roxolid BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM27,400 reports
- STRAUMANN BONE LEVEL TAPERED IMPLANT SLActive Roxolid BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM25,621 reports
- STRAUMANN BONE LEVEL TAPERED IMPLANT SLA Titanium BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM25,298 reports
- Straumann® Dental Implant System Roxolid® SLA Impl. SLA Roxolid BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM23,448 reports
- STRAUMANN BONE LEVEL TAPERED IMPLANT SLActive Roxolid BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM22,320 reports
- STRAUMANN BONE LEVEL TAPERED IMPLANT SLActive Roxolid BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM22,267 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page